| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| USRE39706 | LEO PHARMA AS | Crystalline form of a vitamin D analogue |
Jun, 2015
(8 years ago) | |
| US5763426 | LEO PHARMA AS | Crystalline form of a vitamin D analogue |
Jun, 2015
(8 years ago) | |
Dovonex is owned by Leo Pharma As.
Dovonex contains Calcipotriene.
Dovonex has a total of 2 drug patents out of which 2 drug patents have expired.
Expired drug patents of Dovonex are:
- USRE39706
- US5763426
Dovonex was authorised for market use on 22 July, 1996.
Dovonex is available in cream;topical dosage forms.
The generics of Dovonex are possible to be released after 09 June, 2015.
Drugs and Companies using CALCIPOTRIENE ingredient
Market Authorisation Date: 22 July, 1996
Treatment: NA
Dosage: CREAM;TOPICAL
DOVONEX family patents
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5763426 | LEO PHARM | Crystalline form of a vitamin D analogue |
Jun, 2015
(8 years ago) | |
| USRE39706 | LEO PHARM | Crystalline form of a vitamin D analogue |
Jun, 2015
(8 years ago) | |
Dovonex is owned by Leo Pharm.
Dovonex contains Calcipotriene.
Dovonex has a total of 2 drug patents out of which 2 drug patents have expired.
Expired drug patents of Dovonex are:
- US5763426
- USRE39706
Dovonex was authorised for market use on 03 March, 1997.
Dovonex is available in solution;topical dosage forms.
The generics of Dovonex are possible to be released after 09 June, 2015.
Drugs and Companies using CALCIPOTRIENE ingredient
Market Authorisation Date: 03 March, 1997
Treatment: NA
Dosage: SOLUTION;TOPICAL
DOVONEX family patents